Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10040751 Intermediates for macrocyclic compounds

Patent 10040751 was granted and assigned to Ocera Therapeutics on August, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Ocera Therapeutics

Current Assignee

Ocera Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10040751

Patent Inventor Names

Kamel Benakli0

Mark L. Peterson0

Luc Ouellet0

Sylvie Beaubien0

Sophie Beauchemin0

Carl St-Louis0

Eric Marsault0

Hamid Hoveyda0

Date of Patent

August 7, 2018

Patent Application Number

14873056

Date Filed

October 1, 2015

Patent Primary Examiner

‌

Hasan S Ahmed

Patent abstract

The present invention is directed to novel macrocyclic compounds of formula (I) and their pharmaceutically acceptable salts, hydrates or solvates:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10040751 Intermediates for macrocyclic compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API